154 related articles for article (PubMed ID: 32111152)
1. Comparison of pathway and gene-level models for cancer prognosis prediction.
Zheng X; Amos CI; Frost HR
BMC Bioinformatics; 2020 Feb; 21(1):76. PubMed ID: 32111152
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction.
Zheng X; Amos CI; Frost HR
BMC Cancer; 2021 Sep; 21(1):1053. PubMed ID: 34563154
[TBL] [Abstract][Full Text] [Related]
3. Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models.
Zheng X; Amos CI; Frost HR
BMC Bioinformatics; 2020 Oct; 21(1):467. PubMed ID: 33081688
[TBL] [Abstract][Full Text] [Related]
4. Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.
Zhang X; Li Y; Akinyemiju T; Ojesina AI; Buckhaults P; Liu N; Xu B; Yi N
Genetics; 2017 Jan; 205(1):89-100. PubMed ID: 28049703
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
7. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
Wu Y; Peng Z; Gu S; Wang H; Xiang W
Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
[TBL] [Abstract][Full Text] [Related]
8. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
[TBL] [Abstract][Full Text] [Related]
10. Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA.
Zhao Q; Shi X; Xie Y; Huang J; Shia B; Ma S
Brief Bioinform; 2015 Mar; 16(2):291-303. PubMed ID: 24632304
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel survival prediction model for newly diagnosed lower-grade gliomas.
Zhu Q; Liang Y; Fan Z; Liu Y; Zhou C; Zhang H; He L; Li T; Yang J; Zhou Y; Wang J; Wang L
Neurosurg Focus; 2022 Apr; 52(4):E13. PubMed ID: 35364578
[TBL] [Abstract][Full Text] [Related]
12. A novel non-negative Bayesian stacking modeling method for Cancer survival prediction using high-dimensional omics data.
Shen J; Wang S; Sun H; Huang J; Bai L; Wang X; Dong Y; Tang Z
BMC Med Res Methodol; 2024 May; 24(1):105. PubMed ID: 38702624
[TBL] [Abstract][Full Text] [Related]
13. Identifying the Predictive Role of Oxidative Stress Genes in the Prognosis of Glioma Patients.
Lu D; Yang N; Wang S; Liu W; Zhang D; Wang J; Huang B; Li X
Med Sci Monit; 2021 Nov; 27():e934161. PubMed ID: 34836934
[TBL] [Abstract][Full Text] [Related]
14. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
[TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
16. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
17. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
19. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
20. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
